This morning, hoping to call into question its would-be acquirer, Valeant, Allergan issued a press release quoting the global head of M&A at Morgan Stanley, a blogging Australian hedge fund manager, and me. It was not the beginning of a joke where we all walk into a bar. Tomorrow, Valeant is hosting a conference call to try to rebut what it says are misleading questions about its business model made by Allergan and others.
Hey, check out all the research scientist jobs. Post your resume today!
